Softbank Investment Advisors and existing investor GV contributed to a series C round boosting the drug discovery platform developer's overall funding to over $640m.
US-headquartered drug discovery technology provider Insitro received $400m yesterday in a series C round featuring GV and Softbank Investment Advisors, on behalf of internet technology conglomerate Alphabet and telecommunications and internet group SoftBank.
Canada Pension Plan Investment Board (CPP Investments) led the round, which included Alexandria Venture Investments, the venture capital arm of life sciences real estate investment trust Alexandria Real Estate Equities, as well as an unnamed healthcare provider and undisclosed investment group.
Andreessen Horowitz, Casdin Capital, Arch Venture…
